Drug Shortage Report for VENLAFAXINE XR
Report ID | 36457 |
Drug Identification Number | 02385929 |
Brand name | VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE XR |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 37.5MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2018-01-04 |
Estimated end date | |
Actual end date | 2018-07-02 |
Shortage status | Resolved |
Updated date | 2018-07-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-07-31 | French | Compare |
v3 | 2018-07-31 | English | Compare |
v2 | 2018-01-18 | French | Compare |
v1 | 2018-01-18 | English | Compare |
Showing 1 to 4 of 4